Åse Östholm Balkhed

Author

Åse Östholm Balkhed

Also Known As

Jon Wetterberg, Å Östholm-Balkhed, Å. ÖSTHOLM‐BALKHED, Å. Östholm-Balkhed, Åse Östholm, Åse Östholm Balkhed, Åse Östholm-Balkhed, Åse ÖstholmBalkhed, Östholm-Balkhed, Åse

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Linköping University Karolinska Institutet Karolinska University Hospital Linköping University Hospital Umeå University

ÅÖ

About

Åse Östholm Balkhed is an author at Linköping University specializing in medicine, microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	6	237
2	Microbiology	4	5	175
3	Health Sciences	3	4	135
4	Epidemiology	1	1	19
5	Pharmacology	1	1	30

Åse Östholm Balkhed

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Multiplex PCR amplification assay for the detection of <i> <sup>bla</sup> </i> SHV, <i> <sup>bla</sup> </i> TEM and <i> <sup>bla</sup> </i> CTX‐M genes in <i>Enterobacteriaceae</i> H.‐J. MONSTEIN, Åse Östholm Balkhed, Maud Nilsson, Apmis	2007	353
Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors Åse Östholm Balkhed, Maria Tärnberg, Maud Nilsson, Journal of Antimicrobial Chemotherapy	2013	174
Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study Carl Wahlgren, Gustaf Forsberg, Anestis Divanoglou, The Lancet Regional Health - Europe	2023	100
14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality Martin Holmbom, Christian G. Giske, Mats Fredrikson, PLoS ONE	2016	67
Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting Maria Andersson, Åse Östholm Balkhed, Mats Fredrikson, European Journal of Clinical Microbiology & Infectious Diseases	2019	63
Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms Carl Wahlgren, Anestis Divanoglou, Melanie Larsson, EClinicalMedicine PsychiatrySelf-reported SymptomsSymptomatic TreatmentCovid-19 PandemicRecovery Support	2021	62
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data Karin Welén, Ebba Rosendal, Magnus Gisslén, European Urology	2021	57
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden Charlotta Edlund, Anders Ternhag, Gunilla Skoog, The Lancet Infectious Diseases ProbioticAntimicrobial SusceptibilityHealth SciencesMedicineAntibiotic Adjuvant	2021	43
In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli Maria Tärnberg, Åse Östholm Balkhed, Hans‐Jürg Monstein, European Journal of Clinical Microbiology & Infectious Diseases Antimicrobial SusceptibilityAntibioticsBeta-lactam AntibioticsAntibacterial AgentAntimicrobial Chemotherapy	2011	40
High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden Åse Östholm Balkhed, Maria Tärnberg, Hans‐Jürg Monstein, Scandinavian Journal of Infectious Diseases High FrequencyAntibiotic ResistanceNon-beta-lactam AntibioticsDrug ResistanceEsbl-producing E. Coli	2012	30

Page 1